Silicon Laboratories stock has delivered a strong run over the past year, yet its current valuation checks suggest the shares are not obviously cheap at today’s levels.

• Silicon Laboratories has returned 67.3% over the past 1 year, which puts extra focus on whether the recent share price strength is backed by sustainable fundamentals.
• Recent revenue and profitability improvements, along with new products such as the BG2B low power Bluetooth SoC, may support higher expectations, while the pending acquisition by Texas Instruments introduces deal related uncertainty that can affect how investors price the stock.
• On Simply Wall St’s broader valuation checks, Silicon Laboratories scores 0 out of 6, which points to a share price that currently appears expensive rather than offering a clear bargain.

The issue now is whether Silicon Laboratories’ recent gains leave enough potential upside to justify the current valuation.

Has Silicon Laboratories Run Too Far on Sales?

P/S is a helpful yardstick for Silicon Laboratories because revenue is a clearer anchor than earnings for a company investing heavily in growth and new products.

Right now Silicon Laboratories trades on a P/S of 8.8x. That sits above both the US Semiconductor industry average of 7.1x and the peer group average of 6.1x. The fair P/S multiple for Silicon Laboratories, which takes account of its business profile and risk, is estimated at 7.1x. The current valuation is therefore around 1.7 turns higher than this tailored figure.

Despite the recent Q2 2026 update highlighting stronger revenue and profitability, the P/S multiple already prices Silicon Laboratories at a premium to sector norms. Investors are paying a higher price for each dollar of sales compared with typical semiconductor peers.

On the P/S yardstick, Silicon Laboratories stock screens as overvalued compared with both its fair multiple and the wider Semiconductor industry.

The Silicon Laboratories Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Silicon Laboratories pick up where this valuation puzzle leaves off and set out which combinations of future growth, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price, based on the community’s shared assumptions on the company’s Community page. Rather than relying on a single ratio or model output, they explain the future path that figure rests on so you can monitor whether that story stays on track over time.

Community views on Silicon Laboratories sit on a knife edge, with one camp seeing the story as roughly fairly valued and the other flagging downside risk to expectations.

Bull case: roughly fairly valued

"Expanding IoT deployments and energy-efficient wireless platforms position Silicon Labs for strong revenue growth and improved market share..."

Bear case: 9% overvalued

"If next generation products do not convert the current opportunity funnel into sustained, high volume programs, product mix could drift toward lower contribution parts and compress gross margin from recent 60% plus levels..."

Do you think there's more to the story for Silicon Laboratories? Head over to our Community to see what others are saying!

The Bottom Line

Silicon Laboratories now trades on market multiples that screen as overvalued relative to both its tailored fair P/S and semiconductor peers. That does not rule out further upside, but it means more of the good news around products and profitability is already reflected in the price. The crux from here is whether Silicon Laboratories can deliver the revenue and margin profile that keeps justifying a premium multiple while the Texas Instruments deal plays out. For investors, the key question is whether current expectations for execution and product traction prove conservative or already sit at the optimistic end of the range.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.